CA3118926A1 - Anti-diabetic activity of neem extract and synergistic combinations of urolithins a and b - Google Patents

Anti-diabetic activity of neem extract and synergistic combinations of urolithins a and b Download PDF

Info

Publication number
CA3118926A1
CA3118926A1 CA3118926A CA3118926A CA3118926A1 CA 3118926 A1 CA3118926 A1 CA 3118926A1 CA 3118926 A CA3118926 A CA 3118926A CA 3118926 A CA3118926 A CA 3118926A CA 3118926 A1 CA3118926 A1 CA 3118926A1
Authority
CA
Canada
Prior art keywords
aqueous extract
indica
weeks
ofazadirachta
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3118926A
Other languages
English (en)
French (fr)
Inventor
Muruganandam A. Veeraragavan
Chandan K. Sen
Sanyasi R. Kalidindi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Natreon Inc
Original Assignee
Natreon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Natreon Inc filed Critical Natreon Inc
Publication of CA3118926A1 publication Critical patent/CA3118926A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA3118926A 2018-11-05 2019-11-05 Anti-diabetic activity of neem extract and synergistic combinations of urolithins a and b Pending CA3118926A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN201841041788 2018-11-05
IN201841041788 2018-11-05
US16/672,743 2019-11-04
PCT/US2019/059774 WO2020097014A1 (en) 2018-11-05 2019-11-05 Anti-diabetic activity of neem extract and synergistic combinations of urolithins a and b

Publications (1)

Publication Number Publication Date
CA3118926A1 true CA3118926A1 (en) 2020-05-14

Family

ID=70460249

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3118926A Pending CA3118926A1 (en) 2018-11-05 2019-11-05 Anti-diabetic activity of neem extract and synergistic combinations of urolithins a and b

Country Status (10)

Country Link
US (1) US20200138892A1 (https=)
EP (1) EP3876968A4 (https=)
JP (1) JP2022536223A (https=)
KR (1) KR20210096121A (https=)
CN (1) CN113226347A (https=)
AU (1) AU2019377432A1 (https=)
BR (1) BR112021008725A2 (https=)
CA (1) CA3118926A1 (https=)
MX (1) MX2021005246A (https=)
WO (1) WO2020097014A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220098228A1 (en) * 2020-09-28 2022-03-31 Natreon, Inc. Methods and compositions for improving the immune system and providing immuno-protection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8206753B2 (en) * 2001-06-20 2012-06-26 Metaproteomics, Llc Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes
JP2005325025A (ja) * 2004-05-12 2005-11-24 Green Kanpo Seiyaku Kk 糖尿病予防・治療組成物
WO2006030426A1 (en) * 2004-09-13 2006-03-23 Amcod Limited Herbal compositions for treatment of diabetes

Also Published As

Publication number Publication date
EP3876968A4 (en) 2022-09-14
WO2020097014A1 (en) 2020-05-14
US20200138892A1 (en) 2020-05-07
BR112021008725A2 (pt) 2021-08-03
KR20210096121A (ko) 2021-08-04
EP3876968A1 (en) 2021-09-15
AU2019377432A1 (en) 2021-06-10
JP2022536223A (ja) 2022-08-15
CN113226347A (zh) 2021-08-06
MX2021005246A (es) 2021-09-08

Similar Documents

Publication Publication Date Title
Ansori et al. Medicinal properties of Muntingia calabura L.: A Review
Ahmad et al. Moringa oleifera and glycemic control: A review of current evidence and possible mechanisms
Zhang et al. Research progress of natural active substances with uric-acid-reducing activity
US10166267B1 (en) Multi-component formulations for the treatment of cognitive decline including Alzheimer's disease
TWI678211B (zh) 管花肉蓯蓉萃取物及異類葉升麻苷於保護肌肉之用途
Komalasari et al. A Review on the Anti-diabetic Activity of Andrographis paniculata (Burm. f.) Nees based In-vivo Study
Majeed et al. Novel Emblica officinalis extract containing β-glucogallin vs. metformin: a randomized, open-label, comparative efficacy study in newly diagnosed type 2 diabetes mellitus patients with dyslipidemia
Shadnoush et al. Effects of supplementation with curcuminoids on serum adipokines in critically ill patients: A randomized double‐blind placebo‐controlled trial
Sadino et al. An evidence-based review of Morinda citrifolia L.(Rubiaceae) fruits on animal models, human studies, and case reports
Elbakry et al. Antidiabetic activity of some common medicinal plants
US10183047B2 (en) Chromium-containing compositions in combination with Phyllanthus emblica and shilajit having synergistic effects for improving endothelial function and cardiovascular health
US20200138892A1 (en) Anti-diabetic activity of neem extract and synergistic combinations of urolithins a and b
WO2017159679A1 (ja) 多糖消化阻害剤
KR20190051150A (ko) 장수풍뎅이 유충의 추출물을 함유하는 항알레르기성 조성물
KR101536974B1 (ko) 여주, 산수유, 오미자 및 대추의 혼합 추출물을 함유하는 당뇨 예방 및 개선용 조성물.
US20160015740A1 (en) Chromium-containing compositions for improving endothelial function and cardiovascular health
Gupta et al. Nutraceuticals for diabetes and glucose balance
Agnes Exploring the nutritional benefits of medicinal plants in diabetes management
Kausar et al. Health Benefits Of Herbal Nutraceuticals: An Overview
Tafti et al. Efficacy of herbal supplementation of purslane freeze-dried juice for weight loss: An 8-week randomized, double-blind, placebo-controlled clinical trial
Mani et al. A clinical study on Clitoria ternatea tea therapy to manage diabetic distress in people with type 2 diabetes
Choi et al. Eriobotrya japonica improves cognitive function in healthy adolescents: a 12-week, randomized double-blind, placebo-controlled clinical trial
WO2016186695A1 (en) Synergistic compositions containing chromium with phyllanthus emblica and shilajit for improving endothelial function and cardiovascular health
KR20050102017A (ko) 식초 가공 인삼제제를 이용한 제2형 당뇨병과대사증후군의 예방 및 치료용 조성물
KR20210021846A (ko) 사삼 추출물을 유효성분으로 포함하는 쇼그렌 증후군의 예방 또는 치료용 조성물

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20220829